Circulating Tumor Microemboli Diagnostics for Patients with Non-Small Cell Lung Cancer

INTRODUCTION: Circulating Tumor Microemboli (CTM) are potentially important cancer biomarkers, but using them for cancer detection in early stage disease has been assay limited. We examined CTM test performance using a sensitive detection platform to identify stage I Non-Small Cell Lung Cancer (NSCL...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Carlsson, Anders, Nair, Viswam S., Luttgen, Madelyn S., Keu, Khun Visith, Horng, George, Vasanawala, Minal, Kolatkar, Anand, Jamali, Mehran, Iagaru, Andrei H., Kuschner, Ware, Loo, Billy W., Shrager, Joseph B., Bethel, Kelly, Hoh, Carl K., Bazhenova, Lyudmila, Nieva, Jorge, Kuhn, Peter, Gambhir, Sanjiv S.
Natura: Artigo
Lingua:Inglês
Pubblicazione: 2014
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4145608/
https://ncbi.nlm.nih.gov/pubmed/25157764
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/JTO.0000000000000235
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi